Loading…
Based on limited metadata available, this FDA Warning Letter was issued to Susan P. King-Harris, D.P.M., a healthcare provider or practitioner, regarding biologics products on September 9, 2019. Without access to the full warning letter text or specific subject line details, the exact nature of the violations cannot be determined from the metadata alone. The letter falls under FDA's biologics regulatory jurisdiction, which typically encompasses vaccines, blood products, cellular therapies, and other biological drug products. Additional documentation would be needed to identify the specific compliance issues that prompted this warning.